Cabazitaxel Accord 20 mg/mL concentrate for solution for infusion: Risk of medication errors and mix-up with Jevtana (60 mg/1.5 mL) concentrate and solvent for solution for infusion
About
This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.
Documents
Key facts
| Medicine name |
Cabazitaxel Accord
|
| Active substance |
cabazitaxel
|
| Therapeutic area (MeSH) |
Prostatic Neoplasms, Castration-Resistant
|
| Procedure number |
EMEA/H/C/005178
|
| DHPC type |
Medication error
|
| Human ATC code |
L01CD
|